Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research.
Excitation/Inhibition Modulators in Autism Spectrum Disorder: Current Clinical Research.
复制标题
DOI:
10.3389/fnins.2021.753274
复制
发表时间:
2021
影响因子:
4.3
通讯作者:
Palumbi R
中科院分区:
文献类型:
--
作者:
Canitano R;Palumbi R
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by social and communication abnormalities. Heterogeneity in the expression and severity of the core and associated symptoms poses difficulties in classification and the overall clinical approach. Synaptic abnormalities have been observed in preclinical ASD models. They are thought to play a major role in clinical functional abnormalities and might be modified by targeted interventions. An imbalance in excitatory to inhibitory neurotransmission (E/I imbalance), through altered glutamatergic and GABAergic neurotransmission, respectively, is thought to be implicated in the pathogenesis of ASD. Glutamatergic and GABAergic agents have been tested in clinical trials with encouraging results as to efficacy and tolerability. Further studies are needed to confirm the role of E/I modulators in the treatment of ASD and on the safety and efficacy of the current agents.
登录
查看更多内容
影响因子:
2.6
作者:
Cellot G;Cherubini E
通讯作者:
Cherubini E
影响因子:
1.9
作者:
Cochran, David M.;Sikoglu, Elif M.;Frazier, Jean A.
通讯作者:
Frazier, Jean A.
影响因子:
5.7
作者:
Gaetz, W.;Bloy, L.;Wang, D. J.;Port, R. G.;Blaskey, L.;Levy, S. E.;Roberts, T. P. L.
通讯作者:
Roberts, T. P. L.
影响因子:
1.9
作者:
Aman MG;Findling RL;Hardan AY;Hendren RL;Melmed RD;Kehinde-Nelson O;Hsu HA;Trugman JM;Palmer RH;Graham SM;Gage AT;Perhach JL;Katz E
通讯作者:
Katz E
影响因子:
3.5
作者:
Barahona-Corrêa JB;Velosa A;Chainho A;Lopes R;Oliveira-Maia AJ
通讯作者:
Oliveira-Maia AJ